Home
Pontifax Management 4 G.P. reported a 6.8% stake in AgomAb Therapeutics AGMB · 3,305,846 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.8%
- Last report
- First report
- Shares held
- 3,305,846 sh
- Class
- Common Shares, no nominal value per share
- Event date
- 26/03/31
- Filed
- 26/04/16
First 5%+ report · 6.8% stake
AgomAb Therapeutics trades, last 26 weeks
What else happened in AgomAb Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Pontifax Management 4 G.P.'s other 5% stake reports
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
0% stake
0 sh
0% stake
Filed 25/10/16
- Pontifax Management 4 G.P.
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
6.3% stake
1,411,681 sh
6.3% stake
Filed 25/09/25
- Pontifax Management 4 G.P.
5% stakeClimb Bio
5% stakeClimb Bio
CLYM
7.7% stake
5,206,380 sh
7.7% stake
Filed 25/09/18
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
11.8% stake
4,787,331 sh
11.8% stake
Filed 25/04/18
